FilingReader Intelligence
Livzon Pharmaceutical Group reports progress on A-share and H-share buybacks
April 1, 2025 at 05:28 PM UTC•By FilingReader AI
** Livzon Pharmaceutical Group (SZSE:000513) announced advancements in its ongoing share repurchase programs. As of March 31, 2025, the company repurchased 9,425,955 A-shares, representing 1.03% of the total share capital, at prices ranging from CNY35.18 to CNY38.37 per share, with a total expenditure of CNY341,957,191.15, excluding transaction costs.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
SZSE:000513•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Livzon Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime